(RTTNews) - Toyota Motor North America (TM) Monday said it has partnered with Treehouse to simplify the home electric vehicle charger purchase and installation process for Toyota and Lexus customers.
(RTTNews) - Toyota Motor North America (TM) Monday said it has partnered with Treehouse to simplify the home electric vehicle charger purchase and installation process for Toyota and Lexus customers.
Micron Stock Is Riding the AI Surge. How the Memory Trade Could Turn Sour. Barron's Micron: The Rare Rally Of Melting Multiples Seeking Alpha This Growth Stock Continues to Crush the Market The Motley Fool Micron Is Spending Big to Break the AI Memory Bottleneck The Wall Street Journal Needham Raises Micron (MU) Target to $450, Maintains Buy Rating Yahoo Finance Micron’s AI Memory Pivot Tests Valu...
Micron Stock Is Riding the AI Surge. How the Memory Trade Could Turn Sour. Barron's Micron: The Rare Rally Of Melting Multiples Seeking Alpha This Growth Stock Continues to Crush the Market The Motley Fool Micron Is Spending Big to Break the AI Memory Bottleneck The Wall Street Journal Needham Raises Micron (MU) Target to $450, Maintains Buy Rating Yahoo Finance Micron’s AI Memory Pivot Tests Valuation As US Fab Spending Surges Yahoo Finance
Micron Technology, SK Hynix, and Samsung Electronics are soaring as AI growth creates huge demand for their memory chips. But investors still need to watch for signals of a downturn.
Micron Technology, SK Hynix, and Samsung Electronics are soaring as AI growth creates huge demand for their memory chips. But investors still need to watch for signals of a downturn.
(RTTNews) - Shares of Veris Residential, Inc. (VRE) are climbing around 12 percent on Monday morning trading following the announcement of its fourth-quarter financial results and an agreement to be acquired by an investor consortium led by Affinius Capital in partnership with Vi
(RTTNews) - Shares of Veris Residential, Inc. (VRE) are climbing around 12 percent on Monday morning trading following the announcement of its fourth-quarter financial results and an agreement to be acquired by an investor consortium led by Affinius Capital in partnership with Vi
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise characteristics, with strong earnings trajectories, and are trading at a discount to the estimated private market value. US equities […]
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise characteristics, with strong earnings trajectories, and are trading at a discount to the estimated private market value. US equities […]
US stocks traded lower on Monday as President Donald Trump responded to the Supreme Court’s ruling against his sweeping tariffs by imposing a new, across-the-board 15% levy on US imports, sowing fresh confusion around global trade. Shares of Nvidia Corp. were a bright spot, advancing before Wednesday’s earnings report. The S&P 500 Index was down 0.385% at 9:52 a.m. in New York, with losses in tech...
US stocks traded lower on Monday as President Donald Trump responded to the Supreme Court’s ruling against his sweeping tariffs by imposing a new, across-the-board 15% levy on US imports, sowing fresh confusion around global trade. Shares of Nvidia Corp. were a bright spot, advancing before Wednesday’s earnings report. The S&P 500 Index was down 0.385% at 9:52 a.m. in New York, with losses in technology stocks offsetting gains in energy and health care. Consumer discretionary and industrials sectors were in the red. The Nasdaq 100 Index was down 0.609% . The tariff situation has trigged “mass confusion,” Brian Reynolds , chief market strategist at Reynolds Strategy, wrote in a note Monday. Nonetheless, he expects “tariff rates will be moving lower from the levels that investors feared” almost a year ago, boosting profits this year, particularly for hard-hit small firms. That “could be a modest positive for the economy and equity prices,” he said. Nvidia rose 1.6% as Aletheia Capital raised the stock to a buy, saying it’s too cheap to ignore before earnings. Shares have been drifting sideways for months and are in the bottom half of performers this year for the S&P 500. They were also the most under-owned large-cap tech stock at the end of the fourth quarter. Tech stocks in general were modestly weaker as OpenAI was said to have told investors it’s planning to spend about $600 billion on infrastructure by 2030 after previously saying it was committed to spending more than $1.4 trillion. Energy stocks advanced. Oil prices rose as investors continued to assess the potential for US-led conflict with Iran. What impact will the Supreme Court’s overturning of President Donald Trump’s tariffs have on markets? Let us know . In earnings news, Domino’s Pizza Inc. rallied 4.0% after the company reported US comparable sales topped expectations and boosted its dividend. Novo Nordisk A/S ADRs sank 15% as its next-generation obesity shot CagriSema delivered less weight loss than El...
Douglas Rissing/iStock via Getty Images On February 20, 2026, the Supreme Court issued a 6-3 ruling in which it struck down President Trump's "Liberation Day" and "Reciprocal Tariffs." The Supreme Court determined that the International Emergency Economic Powers Act, or "IEEPA" which was the 1977 law that President Trump used to declare the tariffs, does not grant the President (the executive bran...
Douglas Rissing/iStock via Getty Images On February 20, 2026, the Supreme Court issued a 6-3 ruling in which it struck down President Trump's "Liberation Day" and "Reciprocal Tariffs." The Supreme Court determined that the International Emergency Economic Powers Act, or "IEEPA" which was the 1977 law that President Trump used to declare the tariffs, does not grant the President (the executive branch) the power to impose these tariffs. As most of us remember, the stock market plunged in April 2025, after these tariffs were announced, so it was interesting to see that the market response to this ruling was very muted after the Supreme Court announced the decision. However, there are many potential consequences that might arise from this decision and still create significant uncertainty, as well as stock market volatility. With all this in mind, let's take a closer look: Multi-Billions Of Dollars In Refunds? The Supreme Court Ruling effectively renders the roughly $160-$260 billion worth of tariffs collected over the past year as being illegal. However, the Supreme Court ruling did not address the issue of potential refunds, and for that, the case is being sent to the U.S. Court of International Trade. Importers typically have about 180 days after their goods are finalized by Customs (also known as liquidated) to file a protest. In November 2025, Costco ( COST ) filed a lawsuit with the U.S. Court of International Trade to prevent liquidation and "stop the clock" in an effort to ensure that the tariffs it paid remained legally protestable. Estimates suggest that Costco has paid nearly $1 billion in tariffs since the Liberation Day rollout. Many companies have followed Costco's lead and filed claims to preserve their rights to seek tariff refunds. Even though the Supreme Court ruling seems to be a complete victory for companies like Costco, the process of re-liquidating millions of shipping entries could take months or years. In addition, it remains to be seen if the Tr...
The average of price targets set by Wall Street analysts indicates a potential upside of 35.3% in Broadcom Inc. (AVGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The average of price targets set by Wall Street analysts indicates a potential upside of 35.3% in Broadcom Inc. (AVGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Shares of Broadcom Inc. (AVGO) have gained 3.9% over the past four weeks to close the last trading session at $332.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $450.16 indicates a potential upside of 35.3%. The average comprises 39 short-term price targets rangi...
Shares of Broadcom Inc. (AVGO) have gained 3.9% over the past four weeks to close the last trading session at $332.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $450.16 indicates a potential upside of 35.3%. The average comprises 39 short-term price targets ranging from a low of $335.00 to a high of $535.00, with a standard deviation of $45.71. While the lowest estimate indicates an increase of 0.7% from the current price level, the most optimistic estimate points to a 60.8% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice. However, an impressive consensus price target is not the only factor that indicates a potential upside in AVGO. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside. Price, Consensus and EPS Surprise Here's What You May Not Know About Analysts' Price Targets According to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading. While Wall Stre...
aprott/iStock via Getty Images Thesis: Disappointing REDEFINE 4 Phase III results As you know, Novo Nordisk ( NVO ) has just released top-line results from its REDEFINE 4 Phase 3 obesity trial. Overall, the results are clearly a disappointment relative to investor expectations, and the stock is down almost 14% in pre-market. It was an open-label, 84-week study that compared CagriSema in a fixed-do...
aprott/iStock via Getty Images Thesis: Disappointing REDEFINE 4 Phase III results As you know, Novo Nordisk ( NVO ) has just released top-line results from its REDEFINE 4 Phase 3 obesity trial. Overall, the results are clearly a disappointment relative to investor expectations, and the stock is down almost 14% in pre-market. It was an open-label, 84-week study that compared CagriSema in a fixed-dose combo of cagrilintide 2.4 mg and semaglutide 2.4 mg head-to-head against tirzepatide 15 mg. This was done in about 800 people with obesity/comorbidities. CagriSema produced about a 23.0% mean weight loss under the ‘if all adhered’ estimand and about 20.2% under the more conservative treatment regimen estimand. That first estimand assumes perfect treatment compliance, and the second is a more conservative treatment regimen estimand, which accounts for some treatment discontinuations and real-world adherence behavior. The disappointing numbers were that the tirzepatide delivered 25.5% and 23.6%, respectively. So that means CagriSema failed its primary endpoint of demonstrating non-inferiority versus the market-leading competitor. Management later on the call told us that CagriSema’s efficacy was actually consistent with earlier REDEFINE trials, and then argued the comparator performed unusually well. Novo Nordisk A/S I also think the sentiment on the call didn’t help investors' confidence and somewhat came across as an excuse for the results. Management's view was that the comparator was potentially inflated by the open-label design. What they meant by that is that since investigators knew which drug patients received, and also some had prior experience with tirzepatide, this likely encouraged faster titration and higher dose attainment in that arm. They also noted on the call that not all patients reached full CagriSema dosing, suggesting some efficacy was left on the table. Whilst this may be somewhat true in my opinion, if CagriSema actually had inherent efficacy to out...
Xbox fans had been anticipating the retirement of Microsoft Gaming CEO Phil Spencer for years, but what most hadn't expected was the departure of Xbox president Sarah Bond too. For many outside the company, Bond seemed like Spencer's natural successor, a deputy of sorts. Microsoft CEO Satya Nadella and Microsoft CFO Amy Hood clearly didn't agree. Instead of picking Bond for the role, Microsoft pro...
Xbox fans had been anticipating the retirement of Microsoft Gaming CEO Phil Spencer for years, but what most hadn't expected was the departure of Xbox president Sarah Bond too. For many outside the company, Bond seemed like Spencer's natural successor, a deputy of sorts. Microsoft CEO Satya Nadella and Microsoft CFO Amy Hood clearly didn't agree. Instead of picking Bond for the role, Microsoft promoted Asha Sharma , a former Microsoft AI executive, to the top of Xbox. The decision to overlook Bond might have surprised many Xbox fans, but for the more than a dozen current and former Microsoft employees I've been speaking to, it's felt inev … Read the full story at The Verge.